Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelle I Cedars

Showing results (81-90 of 239) with videos related to

Pageof 24
Sort By:
Obstetrics and Gynecology|June 12, 2018
Interpregnancy Interval and Singleton Live Birth Outcomes From In Vitro FertilizationMolly M Quinn, Mitchell P Rosen, Heather G Huddleston, et al.
Fertility and Sterility|February 15, 2011
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trialJulie D Lamb, Shehua Shen, Charles McCulloch, et al.
American Journal of Obstetrics and Gynecology|May 1, 2004
Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppressionWilliam D Schlaff, Anne M Lynch, Heather D Hughes, et al.
Journal of Assisted Reproduction and Genetics|November 1, 2017
A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocolsYanett Anaya, Douglas A Mata, Joseph Letourneau, et al.
Fertility and Sterility|September 10, 2024
DuoStim: Do we have enough evidence to use it?Filippo Ubaldi, Carlo Alviggi, Juan A Garcia-Velasco, et al.
International Journal of Cancer|April 16, 2016
Irregular menses predicts ovarian cancer: Prospective evidence from the Child Health and Development StudiesPiera M Cirillo, Erica T Wang, Marcelle I Cedars, et al.
Journal of Assisted Reproduction and Genetics|November 28, 2017
Author Correction: A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocolsYanett Anaya, Douglas A Mata, Joseph Letourneau, et al.
Journal of Assisted Reproduction and Genetics|February 9, 2026
Endometrial aging and uterine receptivity: endometrial receptivity analysis (ERA) outcomes in female patients of diverse age groupsKaia M Schwartz, Bahar D Yilmaz, Meagan Chan, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 10, 2013
Birth weight and childhood growth in daughters of women with irregular menstrual cyclesErica T Wang, Piera M Cirillo, Chia-Ning Kao, et al.
Journal of Assisted Reproduction and Genetics|August 26, 2025
Chronic endometritis and its association with implantation history, BCL6, and ERA in infertility patientsBahar D Yilmaz, Kaia M Schwartz, Meagan Chan, et al.
Pageof 24

Showing results (81-90 of 239) with videos related to

Sort By:
Pageof 24
Obstetrics and Gynecology|June 12, 2018
Interpregnancy Interval and Singleton Live Birth Outcomes From In Vitro FertilizationMolly M Quinn, Mitchell P Rosen, Heather G Huddleston, et al.
Fertility and Sterility|February 15, 2011
Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trialJulie D Lamb, Shehua Shen, Charles McCulloch, et al.
American Journal of Obstetrics and Gynecology|May 1, 2004
Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppressionWilliam D Schlaff, Anne M Lynch, Heather D Hughes, et al.
Journal of Assisted Reproduction and Genetics|November 1, 2017
A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocolsYanett Anaya, Douglas A Mata, Joseph Letourneau, et al.
Fertility and Sterility|September 10, 2024
DuoStim: Do we have enough evidence to use it?Filippo Ubaldi, Carlo Alviggi, Juan A Garcia-Velasco, et al.
International Journal of Cancer|April 16, 2016
Irregular menses predicts ovarian cancer: Prospective evidence from the Child Health and Development StudiesPiera M Cirillo, Erica T Wang, Marcelle I Cedars, et al.
Journal of Assisted Reproduction and Genetics|November 28, 2017
Author Correction: A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocolsYanett Anaya, Douglas A Mata, Joseph Letourneau, et al.
Journal of Assisted Reproduction and Genetics|February 9, 2026
Endometrial aging and uterine receptivity: endometrial receptivity analysis (ERA) outcomes in female patients of diverse age groupsKaia M Schwartz, Bahar D Yilmaz, Meagan Chan, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 10, 2013
Birth weight and childhood growth in daughters of women with irregular menstrual cyclesErica T Wang, Piera M Cirillo, Chia-Ning Kao, et al.
Journal of Assisted Reproduction and Genetics|August 26, 2025
Chronic endometritis and its association with implantation history, BCL6, and ERA in infertility patientsBahar D Yilmaz, Kaia M Schwartz, Meagan Chan, et al.
Pageof 24